Natalie Oldham

Natalie Oldham joined Labcorp Biopharmaceutical CMC Services in 2012 and is presently a QC scientist focusing on cell and gene therapy testing, providing scientific and regulatory advice in support of molecules in the preclinical and clinical stages of development.

Natalie studied human biology and infectious disease at the University of Salford and is a key subject matter expert in the development and validation of DNA- and RNA-targeting assays using various nucleotide extraction and qPCR‑based methods within GLP, GCP and GMP regulations.